Clinical trial
Buprenorphine/Naloxone for Opiate-Dependence Treatment - 1
NCT00015028 · National Institute on Drug Abuse (NIDA), NIH · Completed
Key facts
| NCT number | NCT00015028 |
|---|---|
| Title | Buprenorphine/Naloxone for Opiate-Dependence Treatment - 1 |
| Official title | CS1008A Efficacy/Safety Trial of Buprenorphine/Naloxone |
| Lead sponsor | National Institute on Drug Abuse (NIDA), NIH |
| Collaborators | Cincinnati MDRU |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Opioid-Related Disorders, Substance-Related Disorders |
| Intervention type | Drug |
| Interventions | Buprenorphine/naloxone |
| Enrollment | 0 |
| Start date | Nov 1, 1996 |
| Primary completion | Dec 1, 1996 |
| Completion | Jan 1, 1997 |
| First posted | Apr 18, 2001 |
| Last update posted | Jan 16, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: